ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N06AX16 | G | Venlafaxine - 150mg | 11673 | 12822/1 | DEPREVIX HELLAS | 150mg | 30 | Capsule, prolonged release | Oral | Bellapharma S.A.R.L. | Pharmathen SA | Greece | 968,910 L.L | 23.08 | A2 | Pharmathen SA | Greece | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N06AX16 | B | Venlafaxine (HCl) - 150mg | 8824 | 28616/1 | EFEXOR XR | 150mg | 14 | Capsule, sustained release | Oral | Mectapharm S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | 817,056 L.L | 23.08 | A2 | Pfizer Healthcare | Ireland | 2/5/2024 | 0 |
N06AX16 | G | Venlafaxine - 150mg | 8299 | 186181/13 | DEPREVIX HELLAS | 150mg | 30 | Capsule, prolonged release | Oral | Bellapharma S.A.R.L. | Pharmathen SA | Greece | 968,910 L.L | 23.08 | A2 | Pharmathen Hellas SA | Greece | 2/5/2024 | 0 |
N06AX16 | G | Venlafaxine - 150mg | 10594 | 8820/1 | VENLAFAXINE ARROW GENERIQUES LP | 150mg | 30 | Tablet, prolonged release | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 987,724 L.L | 23.08 | A2 | Arrow Génériques | France | 2/5/2024 | 0 |
N06AX16 | G | Venlafaxine HCl - 150mg | 5089 | 23892/07 | VENLAX XR 150 | 150mg | 20 | Capsule, extended release | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 944,529 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
N06AX16 | G | Venlafaxine HCl - 150mg | 8827 | 87716/1 | VENLAX XR 150 | 150mg | 30 | Capsule, extended release | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 1,416,794 L.L | 23.08 | A2 | 2/5/2024 | 0 |